Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Spivak

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Clinical Neuropharmacology|April 15, 1999
The impact of clozapine treatment on serum lipids in chronic schizophrenic patientsB Spivak, C Lamschtein, Y Talmon, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 1, 1995
Effect of dopamine on renal blood flow and cardiac outputI L Gordon, R Wesley, D H Wong, et al.
Human Psychopharmacology|October 31, 2002
The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorderB. Spivak, Y. Vered, R. Yoran-Hegesh, et al.
Biological Psychiatry|September 1, 1997
Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorderB Spivak, B Shohat, R Mester, et al.
Pharmacopsychiatry|March 30, 2004
Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series studyI Reznik, I Yavin, R Stryjer, et al.
The International Journal of Neuropsychopharmacology|October 17, 2001
Analysis of neurosteroid levels in attention deficit hyperactivity disorderR D Strous, B Spivak, R Yoran-Hegesh, et al.
Psychological Medicine|January 15, 2013
Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokersD Shmulewitz, M M Wall, E Aharonovich, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 24, 2000
Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in MoscowB Spivak, D I Maline, V N Kozyrev, et al.
Clinical Neuropharmacology|August 15, 1998
Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapineB Spivak, S Roitman, Y Vered, et al.
International Clinical Psychopharmacology|September 1, 1999
The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agentsB Spivak, E Musin, R Mester, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Neuropharmacology|April 15, 1999
The impact of clozapine treatment on serum lipids in chronic schizophrenic patientsB Spivak, C Lamschtein, Y Talmon, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 1, 1995
Effect of dopamine on renal blood flow and cardiac outputI L Gordon, R Wesley, D H Wong, et al.
Human Psychopharmacology|October 31, 2002
The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorderB. Spivak, Y. Vered, R. Yoran-Hegesh, et al.
Biological Psychiatry|September 1, 1997
Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorderB Spivak, B Shohat, R Mester, et al.
Pharmacopsychiatry|March 30, 2004
Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series studyI Reznik, I Yavin, R Stryjer, et al.
The International Journal of Neuropsychopharmacology|October 17, 2001
Analysis of neurosteroid levels in attention deficit hyperactivity disorderR D Strous, B Spivak, R Yoran-Hegesh, et al.
Psychological Medicine|January 15, 2013
Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokersD Shmulewitz, M M Wall, E Aharonovich, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 24, 2000
Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in MoscowB Spivak, D I Maline, V N Kozyrev, et al.
Clinical Neuropharmacology|August 15, 1998
Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapineB Spivak, S Roitman, Y Vered, et al.
International Clinical Psychopharmacology|September 1, 1999
The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agentsB Spivak, E Musin, R Mester, et al.
Pageof 8